“INVESTIGATING NEURON-SPECIFIC ENOLASE AS A DIAGNOSTIC MARKER FOR EARLY DETECTION OF DIABETIC PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE II DIABETES MELLITUS” (2024) Journal of Population Therapeutics and Clinical Pharmacology, 31(9), pp. 1095–1105. doi:10.53555/jb11kw29.